Could two HPV shots be enough for women with HIV?

NCT ID NCT05495906

Recruiting now ⭐️ VACCINE ⭐️ Sponsor: University of British Columbia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving two doses of the HPV vaccine instead of three can protect women living with HIV just as well. Researchers will compare immune responses in 275 Canadian women aged 18-45 who have not been vaccinated before. If two doses work, it could make HPV vaccination cheaper and easier worldwide, helping to prevent cervical cancer in a high-risk group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease human papilloma virus infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HPV HUMAN IMMUNODEFICIENCY VIRUS HUMAN PAPILLOMA VIRUS

Contacts and locations

Locations

Centre Hospitalier Universitaire Sainte-Justine
RECRUITING

Montreal, Quebec, H3T1C5, Canada
Centre Hospitalier de l'Université Laval
RECRUITING

Québec, Quebec, G1V4G2, Canada
Hamilton Health Sciences
NOT_YET_RECRUITING

Hamilton, Ontario, L8S1A4, Canada
Health Sciences Centre
NOT_YET_RECRUITING

Winnipeg, Manitoba, R3A1R9, Canada
McGill University Health Centre
NOT_YET_RECRUITING

Montreal, Quebec, H4A3J1, Canada
Positive Health Services - Fraser Health
NOT_YET_RECRUITING

Surrey, British Columbia, V3T 0G9, Canada
Regina General Hospital
NOT_YET_RECRUITING

Regina, Saskatchewan, S4P0W5, Canada
St. Michael's Hospital
RECRUITING

Toronto, Ontario, M5B1W8, Canada
Toronto General Hospital
RECRUITING

Toronto, Ontario, M5G2C4, Canada
University of British Columbia
RECRUITING

Vancouver, British Columbia, V6H 2N1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.